AAA State of Play1-877-826-2776
HomeGrant FinderMechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Sponsored by National Institutes of Health

Award
Varies — see funder site
Deadline
January 7, 2027
Geography
Open nationwide

Eligible organization types

  • Open to most organization types — confirm on funder site.

Project types funded

  • Project scope details on funder site.

Need a quote for your grant application?

We’ll prepare a free, application-ready proposal — equipment, surfacing, shipping, and installation.

Get a free proposal 1-877-826-2776